Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT00833560
Eligibility Criteria:
Inclusion Criteria:
* Cytologically or histologically diagnosed with multiple myeloma stage II/III
* Participants without preceding cytostatic (tending to retard cellular activity and multiplication) treatment (pretreatment with radiation or dexamethasone is allowed)
* Agree to use one of the contraception methods as defined in the protocol
* Karnofsky performance status 60 percent or more
* Adequate laboratory test values
Exclusion Criteria:
* Non-secretory multiple myeloma
* Estimated life expectancy less than 3 months
* History of cancer (except basal cell carcinoma) in the last 5 years
* Peripheral neuropathy (disorder of the peripheral nerves) grade 2 or more
* Positive human immunodeficiency virus test and active hepatitis B and/or hepatitis C
* Pregnant or breast-feeding female participants
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00833560
Study Brief:
Protocol Section:
NCT00833560